Vaxart

Vaxart is revolutionizing the way #vaccines are delivered by leveraging its oral vaccine platform. The pill that moves the needle. $VXRT

[Vaxart @Vaxart]

$VXRT’s two newest independent directors James Breitmeyer and Kevin Finney share how their time in the Boardroom has reinforced their confidence that Vaxart’s current directors are best positioned to drive our success. Learn more: https://t.co/c230Y0YiXq

[Vaxart @Vaxart]

Vaxart CEO Steve Lo and CSO Sean Tucker, PhD will participate in two upcoming events surrounding the @IAmBiotech International Convention June 22-25.

Dr. Tucker will participate in a panel at the Taiwan Biotech Forum about innovative therapeutic modalities in precision medicine, and both Steve and Sean will present on the innovation, development and consumer friendly approach of the company’s oral vaccine tablet platform. The discussion will highlight how targeting mucosal immunity via an oral pill could eliminate reliance on traditional needle injections and cold-chain logistics, offering a modern solution to improve global health equity and pandemic readiness.

Read the full release: https://t.co/GL1ZcAgLdU

$VXRT #PillThatMovesTheNeedle #Vaxart #BIO2026 #PillThatMovesTheNeedle #Vaxart #BIO202

[Vaxart @Vaxart]

$VXRT is doing the work to validate our oral vaccine platform, and your Board understands what it takes to build value in biotechnology.

Protect your investment. Vote the WHITE proxy card “FOR” ALL 6 of Vaxart’s highly qualified director nominees.

Learn more: https://t.co/LUR8QbK2HF

[Vaxart @Vaxart]

$VXRT shareholders, your vote is especially important this year. We urge you to vote the WHITE proxy card today “FOR” ALL 6 of Vaxart’s highly qualified directors and WITHHOLD on the shareholder nominees.

Learn more: https://t.co/AwbT7REiDM

[Vaxart @Vaxart]

Today we honor and remember the courageous individuals who made the greatest sacrifice for our country.

[Vaxart @Vaxart]

$VXRT is entering a pivotal phase to demonstrate the potential of our unique oral vaccine platform. We need our shareholders’ support, so our Board can continue working with urgency to capture the opportunities ahead and create value. Learn more: https://t.co/c230Y0YiXq

[Vaxart @Vaxart]

Vaxart today announced first quarter 2026 financial results.

The Company will be hosting a fireside chat tomorrow, May 8 at 4:30 PM ET to answer frequently asked questions from stockholders.

Read the full release: https://t.co/h75XdqqyRu

#PillThatMovesTheNeedle $VXRT

[Vaxart @Vaxart]

#Vaxart will report first quarter 2026 financial results on Thursday, May 7 with a fireside chat on May 8 at 4:30PM ET to answer stockholders' frequently asked questions.

The live fireside chat can be accessed here: https://t.co/kjWQNWM0NT

#PillThatMovesTheNeedle $VXRT

[Vaxart @Vaxart]

Vaxart appoints James Breitmeyer to its Board of Directors.

With more than 35 years of biopharmaceutical experience and eight FDA product approvals, James brings a wealth of knowledge and extensive drug development expertise to Vaxart’s Board.

Read more: https://t.co/qiwt7g1XfU

[Vaxart @Vaxart]

Dr. Sean Tucker, our Founder and CSO, connected with @VaccineInsights to discuss how #Vaxart is reimagining vaccine delivery with oral tablet immunization, what led him to focus on oral vaccines and more.

Read the interview: https://t.co/ZdG1LvAC2A

$VXRT #PillThatMovesTheNeedle

[Vaxart @Vaxart]

At @vaccinenation, Dr. James F. Cummings, our Chief Medical Officer, shared insights on next generation pandemic vaccine development and how Vaxart’s oral pill vaccine platform can improve how we address public health challenges.

#WorldVaccineCongress #WVCDC #Vaxart

[Vaxart @Vaxart]

Vaxart today announced fourth quarter and full year 2025 financial results.

Tune into our conference call today at 4:30 PM ET for key business updates.

Read the full release: https://t.co/WHmwRGfLbs

$VXRT

[Vaxart @Vaxart]

$VXRT will host two upcoming conference calls:

Full Year 2025 Financial Results Update: March 12 @ 4:30PM ET

Vaxart Stockholder Virtual Fireside Chat: March 13 @ 4:30PM ET

Call details including webcast links can be found here: https://t.co/8gm7VR29gg

#PillThatMovesTheNeedle

[Vaxart @Vaxart]

$VXRT today announced that members of the management team will present at the @Oppenheimer 36th Annual Healthcare Life Sciences Conference on Wednesday, February 25 at 4:00 PM ET.

Register to join the live webcast: https://t.co/RQTPfbjen8

[Vaxart @Vaxart]

This #MLKDay, we honor Dr. King's legacy of equality, justice, and hope. Let’s reflect on his impact and how we can build a more inclusive and equitable future together.

[Vaxart @Vaxart]

$VXRT has announced the publication of positive data for its oral bivalent norovirus candidate in lactating women and their infants.

To learn more, read the full release: https://t.co/1CcdgyTjEe

Access the publication here: https://t.co/pvz1RQDWOq

[Vaxart @Vaxart]

As 2025 comes to a close, we’re taking a moment to rest, reflect, and recharge. It’s been a year of challenges, growth, and meaningful progress—and we couldn’t have done it without our incredible team, partners, and community. Wishing everyone a joyful and peaceful holiday season

[Vaxart @Vaxart]

Dr. Sean Tucker, our Founder and CSO, discussed our oral vaccine platform in an interview with Tyler Menichiello of Bioprocess Online.

Tune into this informative discussion here (subscription required): https://t.co/ykQg29KAqa

#PillThatMovesTheNeedle

[Vaxart @Vaxart]

This Thanksgiving, we’re grateful for our dedicated team and the achievements and the challenges we’ve overcome together. Wishing everyone a peaceful and joyful holiday.